Traitement des carcinoses péritonéales d'origine colo-rectale. Quoi ...

Références
1. Benoit L, Cheynel N, Ortega-Deballon P, Giacomo GD, Chauffert B, Rat P. Closed hyperthermic
intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the
surgical team to chemotherapy drugs. Ann Surg Oncol. 2008 Feb;15(2):542-6.
2. Boulin M, Guiu S, Chauffert B, Aho S, Cercueil JP, Ghiringhelli F, Krause D,Fagnoni P, Hillon P, Bedenne
L, Guiu B. Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma.
Anticancer Drugs. 2011 Apr 11.
3. Ceelen WP, Bracke ME. Peritoneal minimal residual disease in colorectal cancer: mechanisms,
prevention, and treatment. Lancet Oncol. 2009 Jan;10(1):72-9.
4. Chauffert B, Favoulet P, Polycarpe E, Duvillard C, Beltramo JL, Bichat F, Rat P, Genne P, Benoit L.
Rationale supporting the use of vasoconstrictors for intraperitoneal chemotherapy with platinum
derivatives. Surg Oncol Clin N Am. 2003 Jul;12(3):835-48.
5. Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, Rougier P, Ducreux M. Curative treatment of
peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal
chemotherapy. Cancer 2001; 92: 71-76
6. Esquis P, Consolo D, Magnin G, Pointaire P, Moretto P, Ynsa MD, Beltramo JL, Drogoul C, Simonet M,
Benoit L, Rat P, Chauffert B. High intra-abdominal pressure enhances the penetration and antitumor
effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006
Jul;244(1):106-12.
7. Facy O, Radais F, Ladoire S, Delroeux D, Tixier H, Ghiringhelli F, Rat P, Chauffert B, Ortega-Deballon P.
Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in
a murine model of peritoneal carcinomatosis. J Exp Clin Cancer Res. 2011 Jan 7;30:4.
8. Guardiola E, Chauffert B, Delroeux D, Royer B, Heyd B, Combe M, Benoit L, Causeret S, Demarchi M,
Magnin G, Mayer F, Tixier H, Pivot X. Intraoperative chemotherapy with cisplatin and epinephrine
after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study. Anticancer
Drugs. 2010 Mar;21(3):320-5.
9. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y,
Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-
Portilla A, Shen P, Deraco M, Rat P. Cytoreductive surgery combined with perioperative intraperitoneal
chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a
multiinstitutional study. J Clin Oncol 2004; 22: 3284-3292
10. Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B,Lorimier G, Msika S, Elias D;
French Surgical Association. Toward curative treatment of peritoneal carcinomatosis from nonovarian
origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-
institutional study of 1,290 patients. Cancer. 2010 (a) Dec 15;116(24):5608-18.
11. Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, Bereder JM, Lorimier G, Quenet F, Elias
D; Association Française de Chirurgie. Peritoneal carcinomatosis from gastric cancer: a multi-
FCC 8 - Traitement des carcinoses péritonéales d'origine colo-rectale - quoi de neuf depuis le
rapport de l'AFC en 2008 ?